The

drugs

industry closed the day down 0.1%.

BioDelivery Sciences International Inc

(

BDSI

),

Aoxing Pharmaceutical Company Inc

(

AXN

),

NeurogesX Inc

(

NGSX

), and

Marina Biotech Inc

(

MRNA

) were all decliners today within the drugs industry with

Cytori Therapeutics Inc

(

CYTX

) being today's featured drugs loser. Cytori Therapeutics Inc fell 9 cents (-3%) to $2.92 on average volume. Throughout the day, 577,576 shares of Cytori Therapeutics Inc exchanged hands as compared to its average daily volume of 453,700 shares.

Cytori Therapeutics, Inc. engages in the development, manufacture, and sale of medical products and devices to enable the practice of regenerative medicine. Regenerative medicines focus on repairing or restoring lost or damaged tissue and cell function. Cytori Therapeutics Inc has a market cap of $172.6 million and is part of the

health care

sector. Shares are down 36.6% year to date as of the close of trading on Wednesday.

TheStreet Ratings rates Cytori as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally weak debt management and generally disappointing historical performance in the stock itself.

On the positive front,

TheStreet Recommends

ProPhase Labs Inc

(

PRPH

),

Cardium Therapeutics Inc

(

CXM

),

Galena Biopharma Inc

(

RXII

), and

Senesco Technologies Inc

(

SNT

) were all gainers within the drugs industry with

Pfizer Inc

(

PFE

) being today's featured drugs industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider

SPDR S&P Pharmaceuticals ETF

(

XPH

) while those bearish on the drugs industry could consider

ProShares UltraShort Nasdaq Biotech

(

BIS

).

null